| Q68242318 | Acute renal failure |
| Q55001414 | Changing Paradigms in Contrast Nephropathy. |
| Q40202899 | Coadministration of Liposomal Amphotericin B and Contrast Medium Does Not Increase Risk of Kidney Injury |
| Q91291961 | Contrast Induced Acute Kidney Injury and its Impact on Mid-Term Kidney Function, Cardiovascular Events and Mortality |
| Q68174186 | Contrast nephropathy in patients with impaired renal function: high versus low osmolar media |
| Q38006819 | Contrast-induced nephropathy in patients with renal insufficiency undergoing contrast-enhanced MDCT. |
| Q53132130 | Contrast-induced nephropathy: doubts and certainties. |
| Q53057193 | Coronary computed tomography angiography - tolerability of β-blockers and contrast media, and temporal changes in radiation dose. |
| Q58386419 | Does the Current Definition of Contrast-induced Acute Kidney Injury Reflect a True Clinical Entity? |
| Q89743199 | Effect of No Prehydration vs Sodium Bicarbonate Prehydration Prior to Contrast-Enhanced Computed Tomography in the Prevention of Postcontrast Acute Kidney Injury in Adults With Chronic Kidney Disease: The Kompas Randomized Clinical Trial |
| Q38057668 | Emergency noninvasive angiography for acute intracerebral hemorrhage. |
| Q40559288 | Estimating the Risk of Radiocontrast-Associated Nephropathy |
| Q53446435 | Evaluation of urine fibrinogen level in a murine model of contrast-induced nephropathy. |
| Q33862673 | Functional contrast-enhanced CT for evaluation of acute ischemic stroke does not increase the risk of contrast-induced nephropathy. |
| Q45043102 | Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version : JSN, JRS, and JCS Joint Working Group. |
| Q45334831 | Guidelines on the use of iodinated contrast media in patients with kidney disease 2012: digest version. JSN, JRS, and JCS Joint Working Group |
| Q38789239 | Imaging patients with renal impairment |
| Q37946760 | Intravascular contrast agents and renal failure |
| Q38077608 | Intravenous contrast material-induced nephropathy: causal or coincident phenomenon? |
| Q33577249 | Lower incidence of contrast-induced nephropathy in patients undergoing fluorescent angiography |
| Q39389778 | Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review |
| Q35882934 | Prevention of Contrast-Induced Nephropathy (CIN) in Interventional Radiology Practice |
| Q93609063 | References |
| Q36925859 | Risk of contrast induced nephropathy in the critically ill: a prospective, case matched study |
| Q37149577 | Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis |
| Q43121489 | Screening for renal insufficiency following ESUR (European Society of Urogenital Radiology) guidelines with on-site creatinine measurements in an outpatient setting |
| Q87393341 | Section 4: Contrast-induced AKI |
| Q34101150 | Should nonionic radiographic contrast media be given to all patients? |
| Q35167914 | The cost-utility of CT angiography and conventional angiography for people presenting with intracerebral hemorrhage |
| Q34523413 | The incidence and prognostic significance of acute kidney injury |
| Q73218047 | The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography |
| Q35593219 | Use of cystatin C and serum creatinine for the diagnosis of contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography at an oncology centre |